Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm3
Keyword(s):
2020 ◽
Vol 34
(9)
◽
pp. 2026-2034
◽
1995 ◽
Vol 13
(12)
◽
pp. 1847???1851
◽
Keyword(s):
2007 ◽
Vol 6
(2)
◽
pp. 83-86
◽
2016 ◽
Vol 15
(4)
◽
pp. 549-557
◽
Keyword(s):
1992 ◽
Vol 21
(2)
◽
pp. 85-91
◽
Keyword(s):
2012 ◽
Vol 66
(4)
◽
pp. AB10
◽